The prognostics value of CTCs enriched by the ISET method has been demonstrated in the context of multiple cancers, such as Hepato-Cellular Carcinoma, Non-Small-Cell Lung Cancer, Small-Cell Lung, Uveal Melanoma, Colorectal Cancer, Pancreatic Cancer, Head and Neck, Ovarian Cancer and Soft Tissue Sarcoma.
Examples of Kaplan-Meyer curves disease-free survival duration stratified according to the presence or absence of CTCs are presented in the images below.